Alcohol

Alcohol

SCHEMBL240704

CC(O)S.CCO

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106106473-A A kind of compositions preventing and treating Caulis et Folium Brassicae capitatae diamondback moth and preparation method thereof 殷佩琼 2016-11-16 CN claimed
CN-107998897-A A kind of surface hydrophilic modification method of Pvdf Microporous Hollow Fiber Membrane 北京化工大学 2018-05-08 CN disclosed
CN-107589254-A A kind of manufacture method of immunoliposome complex nano-particle biochip and application 奈尔公司 2018-01-16 CN disclosed
CN-106106473-A A kind of compositions preventing and treating Caulis et Folium Brassicae capitatae diamondback moth and preparation method thereof 殷佩琼 2016-11-16 CN disclosed
EP-2171043-B1 TREATMENT OF DISEASES AND DISORDERS USING SELF-RENEWING COLONY FORMING CELLS CULTURED AND EXPANDED IN VITRO GARNET BIOTHERAPEUTICS INC (US) 2015-03-18 EP disclosed
US-20140099329-A1 TREATMENT OF DISEASES AND DISORDERS USING SELF-RENEWING COLONY FORMING CELLS CULTURED AND EXPANDED IN VITRO GARNET BIOTHERAPEUTICS, INC. (US) 2014-04-10 US disclosed
US-20140086884-A1 TREATMENT OF DISEASES AND DISORDERS USING SELF-RENEWING COLONY FORMING CELLS CULTURED AND EXPANDED IN VITRO Gamet BioTherapeutics, Inc., (US) 2014-03-27 US disclosed
US-20130266542-A1 Compositions and Methods of Using Living and Non-Living Bioactive Devices with Components Derived From Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro Garnet BioThereapeutics, Inc. (US) 2013-10-10 US disclosed
US-20130259837-A1 Compositions and Methods of Using Living and Non-Living Bioactive Devices with Components Derived From Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro GARNET BIOTHERAPEUTICS INC (US) 2013-10-03 US disclosed
EP-2575441-A1 COMPOSITIONS AND METHODS OF USING LIVING AND NON-LIVING BIOACTIVE DEVICES WITH COMPONENTS DERIVED FROM SELF-RENEWING COLONY FORMING CELLS CULTURED AND EXPANDED IN VITRO Garnet BioTherapeutics, Inc (US) 2013-04-10 EP disclosed
US-8354370-B2 Administering a biological composition or compositions isolated from self-renewing colony forming somatic cell growth medium to treat diseases and disorders GARNET BIOTHERAPEUTICS, INC. (US) 2013-01-15 US disclosed
US-20120156192-A1 Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro GARNET BIOTHERAPEUTICS, INC. (US) 2012-06-21 US disclosed
US-20120148544-A1 Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro GARNET BIOTHERAPEUTICS, INC. (US) 2012-06-14 US disclosed
US-20120121555-A1 Compositions and Methods of Using Living and Non-Living Bioactive Devices with Components Derived From Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro GARNET BIOTHERAPEUTICS, INC. (US) 2012-05-17 US disclosed
US-20120003188-A1 Compositions and Methods of Using Living and Non-Living Bioactive Devices with Components Derived from Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro GARNET BIOTHERAPEUTICS, INC. (US) 2012-01-05 US disclosed
WO-2011150398-A1 COMPOSITIONS AND METHODS OF USING LIVING AND NON-LIVING BIOACTIVE DEVICES WITH COMPONENTS DERIVED FROM SELF- RENEWING COLONY FORMING CELLS CULTURED AND EXPANDED IN VITRO GARNET BIOTHERAPEUTICS, INC (US) 2011-12-01 WO disclosed
EP-2171043-A1 TREATMENT OF DISEASES AND DISORDERS USING SELF-RENEWING COLONY FORMING CELLS CULTURED AND EXPANDED IN VITRO Garnet BioTherapeutics, Inc (US) 2010-04-07 EP disclosed
US-20090053183-A1 Treatment of Diseases and Disorders Using Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro NEURONYX INC. (US) 2009-02-26 US disclosed
WO-2008156728-A1 TREATMENT OF DISEASES AND DISORDERS USING SELF-RENEWING COLONY FORMING CELLS CULTURED AND EXPANDED IN VITRO NEURONYX, INC. (US) 2008-12-24 WO disclosed